Serum levels of hyaluronic acid are associated with COPD severity and predict survival
European Respiratory Journal Feb 04, 2019
This article published in European Respiratory Journal throws light on the association of degradation of hyaluronic acid with airflow limitation and impairment of lung function.
Papakonstantinou E, et al. - Given the significant role of hyaluronic acid (HA) and its degradation products in lung pathophysiology and airway remodeling in COPD, researchers investigated whether HA and its degrading enzyme hyaluronidase-1 (HYAL-1) are associated with COPD severity and outcome.
In a discovery cohort of 80 COPD patients at stable state and exacerbations, serum HA was assessed. They examined 638 COPD patients from the PROMISE validation cohort for HA, HYAL-1, and HYAL-1 enzymatic activity at stable state, exacerbations, and 4 weeks after exacerbations. In the discovery cohort, they observed higher serum HA at exacerbations vs stable disease. Higher HA was noted at moderate and severe exacerbations vs baseline and remained higher after 4 weeks in the validation cohort.
HA was noted to be strongly predictive for overall survival as it was correlated with time to death independently of adjusted Charlson-score, annual exacerbation rate, and BODE-index. Association of degradation of HA with airflow limitation and impairment of lung function was evident.
Sign-up to continue reading. It is free & takes less than 2 mins
45 lakhs+ doctors trust M3 globally
Free & unlimited access to original articles and quizzes
Secure: we never sell your data
Sign up with M3 India to try daily quizzes and take part in competitionsTry M3 India / Log In
Why join our Market Research Panel?
- 10K+ Doctors participated in 40+ Indian and Global studies in 2018
- Average honorarium per study was Rs. 1,600 and total honoraria as high as Rs. 12,000 was earned by a Doctor